Recommended

New webinar with Fujifilm: Monocyte activation test (MAT): Insight into examining regulations and markets prospects
New webinar: The path to optimisation in pharmaceutical microbiology
Join our webinar: An alternative medium to support sterility testing using the Growth Direct® Rapid Sterility System
Discover more in our new application note: validating recombinant cascade reagents in 3 simple steps
Webinar

The hidden costs of microbial misidentifications

Doug Botkin, PhD, examines the challenges and consequences of inaccurate microbial identification methods using real-world case studies and discusses how these challenges can be addressed.

About this webinar

This webinar  examines a real-world case study where inaccurate microbial identification methods led a company down an erroneous and costly investigation path.

Although an extensive review of historical environmental monitoring tracking and trending data was performed, an initial incorrect microbial identification resulted in three discarded batches, production line work stoppages and countless months sampling and cleaning equipment.

This finding enabled the company to identify a root cause and learn about accurate microbial identification methods.

Key takeaways

  • Avoid common mistakes in the development of contamination control strategies
  • Determine the origin of contamination and learn how to take preventative actions to prevent recurrence
  • Generate consistent, reliable IDs that inform your EM and microbial investigations
  • Develop a streamlined CCS.

By watching you will also have the opportunity to hear any answers from the speakers during the Q&A session at the end of the presentation.

Our speaker

Dr Doug Botkin, Technology & Market Development Manager, Charles River Laboratories

Dr Doug Botkin is a Technology and Market Development Manager at Charles River Laboratories. He is a subject matter expert in the Microbial Solutions group, focusing on Accugenix products and services for microbial identifications. Doug has over 24 years of experience in infectious disease research, spaceflight microbiology and pharmaceutical microbiology, including working as a QC microbiologist in 503B outsourcing, cell and gene therapy and non-sterile manufacturing sites. He holds a bachelor’s degree in Biological Sciences from Illinois State University and earned his PhD in Microbiology and Molecular Genetics from The University of Texas Health Science Center at Houston.